Can online chats help latinx teens master diabetes tech?

NCT ID NCT06546930

Ongoing Knowledge-focused Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether virtual peer groups can help Latinx teenagers with type 1 diabetes use insulin pumps and continuous glucose monitors more effectively. About 120 teens and their caregivers will join online sessions covering topics like family relationships, school, and working with their care team. The main goal is to see if the program is feasible and acceptable, not yet to prove it improves health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: virtual peer group intervention
What this could lead to: If successful, this could show that peer support groups help Latinx teens with type 1 diabetes use technology better, potentially improving their glucose control and reducing complications.
What could go wrong: This is an early feasibility study with only 120 participants, so results may not apply broadly. The intervention is behavioral, not a drug, so any benefits are likely modest and depend on engagement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 1 diabetes mellitus type 1 diabetes mellitus 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 1

Contacts and locations

Locations

Children's Hospital Los Angeles

Los Angeles, California, 90027, United States
University of California, Davis

Davis, California, 95616, United States
University of California, San Francisco

San Francisco, California, 94158, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.